Literature DB >> 10389879

Long-term outcomes after meningioma radiosurgery: physician and patient perspectives.

D Kondziolka1, E I Levy, A Niranjan, J C Flickinger, L D Lunsford.   

Abstract

OBJECT: Stereotactic radiosurgery is a primary or adjuvant management approach used to treat patients with intracranial meningiomas. The goal of radiosurgery is long-term prevention of tumor growth, maintenance of the patient's neurological function, and prevention of new neurological deficits. The object of this study is to report longer-term patient outcomes.
METHODS: The authors evaluated 99 consecutive patients who underwent radiosurgery for meningioma between 1987 and 1992. Evaluation was performed using serial imaging tests, clinical evaluations, and a patient survey that was administered between 5 and 10 years after radiosurgery. Four patients underwent two radiosurgery procedures for separate meningiomas. The average tumor margin dose was 16 Gy and the median tumor volume was 4.7 ml (range 0.24-24 ml). Fifty-seven patients (57%) had undergone prior resection, of which 12 procedures were considered "total." Five patients received fractionated radiation therapy before radiosurgery. Eighty-nine patients (89%) had skull base tumors. The clinical tumor control rate (no resection required) was 93%. Sixty-one (63%) of 97 tumors became smaller, 31 (32%) remained unchanged in size, and five (5%) were enlarged. Resection was performed in seven patients (7%), six of whom had undergone prior resection. New neurological deficits developed in five patients (5%) 3 to 31 months after radiosurgery. Twenty-seven (42%) of 65 responding patients were employed at the time of radiosurgery and 20 (74%) of these remained so. Radiosurgery was believed to have been "successful" by 67 of 70 patients who completed an outcomes questionnaire 5 to 10 years later. At least one complication was described by nine patients (14%) and in four patients the complications resolved.
CONCLUSIONS: Five to 10 years after radiosurgery, 96% of surveyed patients believed that radiosurgery provided a satisfactory outcome for their meningioma. Overall, 93% of patients required no other tumor surgery. Incidences of morbidity in this early experience were usually transitory and relatively mild. Radiosurgery provided long-term tumor control associated with high rates of neurological function preservation and patient satisfaction.

Entities:  

Mesh:

Year:  1999        PMID: 10389879     DOI: 10.3171/jns.1999.91.1.0044

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  39 in total

1.  Efficacy of conventional radiotherapy for recurrent meningioma.

Authors:  M Kokubo; Y Shibamoto; J A Takahashi; K Sasai; N Oya; N Hashimoto; M Hiraoka
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Impaired survival and long-term neurological problems in benign meningioma.

Authors:  Hanna van Alkemade; Michelle de Leau; Edith M T Dieleman; Jan W P F Kardaun; Rob van Os; W Peter Vandertop; Wouter R van Furth; Lukas J A Stalpers
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

3.  The effect of large single radiation doses on cochlear implant function: implications for radiosurgery.

Authors:  Thomas Klenzner; Johannes Lutterbach; Antje Aschendorff; Peter Pedersen; Mathias Stecker; Roland Laszig
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-09-18       Impact factor: 2.503

Review 4.  Linac radiosurgery as a tool in neurosurgery.

Authors:  R Deinsberger; J Tidstrand
Journal:  Neurosurg Rev       Date:  2005-02-22       Impact factor: 3.042

Review 5.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

Review 6.  The biology of radiosurgery and its clinical applications for brain tumors.

Authors:  Douglas Kondziolka; Samuel M Shin; Andrew Brunswick; Irene Kim; Joshua S Silverman
Journal:  Neuro Oncol       Date:  2014-09-28       Impact factor: 12.300

7.  A review of stereotactic radiosurgery practice in the management of skull base meningiomas.

Authors:  Elena Vera; J Bryan Iorgulescu; Daniel M S Raper; Karthik Madhavan; Brian E Lally; Jacques Morcos; Samy Elhammady; Jonathan Sherman; Ricardo J Komotar
Journal:  J Neurol Surg B Skull Base       Date:  2014-03-12

8.  Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

Authors:  Patrick Y Wen; W K Alfred Yung; Kathleen R Lamborn; Andrew D Norden; Timothy F Cloughesy; Lauren E Abrey; Howard A Fine; Susan M Chang; H Ian Robins; Karen Fink; Lisa M Deangelis; Minesh Mehta; Emmanuelle Di Tomaso; Jan Drappatz; Santosh Kesari; Keith L Ligon; Ken Aldape; Rakesh K Jain; Charles D Stiles; Merrill J Egorin; Michael D Prados
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

9.  Complications after gamma knife radiosurgery for benign meningiomas.

Authors:  J H Chang; J W Chang; J Y Choi; Y G Park; S S Chung
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

10.  Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.

Authors:  Ernesto Maranzano; Lorena Draghini; Michelina Casale; Fabio Arcidiacono; Paola Anselmo; Fabio Trippa; Cesare Giorgi
Journal:  Strahlenther Onkol       Date:  2015-10-21       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.